홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Formamide → Quinazoline

HRID 1803014
인쇄

반응식

HRID 1803014 반응식
CO[C:3]1[CH:4]=[C:5]2[N:22]=[CH:21][N:20]=[C:19](NC3C=CC(F)=C(Cl)C=3)[C:6]2=[CH:7][C:8]=1OCCCN1CCOCC1.OC1C=C(C=CC=1OC)C#N.O1CCN(CCCCl)CC1.S(S([O-])=O)([O-])=O.[Na+].[Na+].C(N)=O>>[N:22]1[C:5]2[C:6](=[CH:7][CH:8]=[CH:3][CH:4]=2)[CH:19]=[N:20][CH:21]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

6

반응물 5

HCID 713FormamideHCID 24489Sodium DithioniteHCID 958344-(3-Chloropropyl)morpholineHCID 123631GefitinibHCID 49128223-Hydroxy-4-methoxybenzonitrile2회

생성물 1

HCID 9210Quinazoline

실험 절차

WO 2004/024703 discloses a process for the preparation of gefitinib starting from 3-hydroxy-4-methoxy benzonitrile which involves condensation of 3-hydroxy-4-methoxy benzonitrile with morpholino propyl chloride, nitration, reduction with sodium dithionite to amino compound, hydrolysis of nitrile to amide, cyclisation in the presence of formamide to obtain quinazoline, chlorination with phosphorous oxychloride and finally condensation with chloro-fluoro aniline to obtain gefitinib. The process involves multiple steps and hence is time consuming.

출처 및 근거

ORD 기록
ord-03eb032aa21040a8a01c2c7707c6ff57
출처 데이터셋
uspto-grants-2013_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08350029B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트